Jaguar Health, Inc. (JAGX) Social Stream



Jaguar Health, Inc. (JAGX): $1.31

0.07 (+5.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add JAGX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 492

in industry

Featured Post From StockTwits About JAGX

$JAGX Answer: you can expect great things Monday, this was more than a million shares!! Closer to 8 million shares that were gobbled up in one day by accredited investor/investors. Likely, more than one since it would be 5% ownership. Either way, the Direct placement will be complete Monday. Certainly was good news that they went quickly!
BuyTheGap_, published April 30, 2021

What Else are JAGX Traders Talking About?


Other tickers frequently mentioned alongside JAGX are TRCH, SNDL, ZOM and OCGN.

Other Notable StockTweets About JAGX


$JAGX "Penny flipping" with 50k, sold at 1.70 on open and bought back at 1.61, easy enough on a stock like this

Long term bullish btw, original holding of 35k shares at 0.82 sitting pretty, just making change on the way

Milne, published April 27, 2021

$TRCH breakout is 1.82! It looks like we have no resistance until then! Could test 2.00 today easily! Let’s goooooo! The shareholder meeting and dividend announcement is next week! Shorts becoming bulls now ! $SNDL $ZOM $OCGN $JAGX @ACInvestorBlog @topstockalerts @WalIstbets @BullTradeFinder ...meta is gonna be huge

BullsAndBags, published April 22, 2021

$JAGX so they had the required amount of participants to begin their 24 week study in phase 3 beginning October 7th. Week after next is 24 weeks and assuming everything went smoothly, the study should be finishing up these couple of weeks which just happens to coincide with the NAPO incorporation. I know clinical trials.gov has the estimate at March 2023, but again, that’s just an estimate. I’m curious and excited for this coming year, I expect big things

Legacytrade11, published April 18, 2021

$JAGX "Even if Proposal 3 is approved at the Annual Meeting, the Board reserves the right to elect not to proceed with and abandon the Amendment if circumstances change and it determines, in its sole discretion at any time, that this proposal is no longer in the best interests of our stockholders. In addition, if the Board determines that it is advisable and in the Company?s best interests to change the number of authorized shares of our Common Stock other than an increase to 290 million authorized shares of Common Stock, the Board would have to approve such amendment to the COI changing the number of authorized shares of our Common Stock and submit such amendment to the stockholders of the Company for approval prior to the Company implementing any such change in the number of authorized shares of our Common Stock. "

ohPorsche, published April 13, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5054 seconds.